MMMM D, YYYY

Clinical Study Results Sanofi Pharma, including Sanofi Genzyme



Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter D

Generic Name Trade Name Condition Study Code Study Name Access to study Access to results
DOCETAXEL Taxotere Prostate Cancer, Hormone Refractory ARD6562 (XRP6976J/2101) NA NCT00291005
DOCETAXEL Taxotere Cancer, Prostate, Hormone Refractory ARD6563 (XRP6976J/2102) NANCT00723086
DOCETAXEL Taxotere Breast Neoplasms DOCET_L_00712NA NCT00364611
DOCETAXEL TaxotereBreast Neoplasms DOCET_L_00713 NA NCT00446030
DOCETAXELTaxotere Non Small Cell Lung Cancer DOCET_L_00714 NA NCT00365365
DOCETAXEL Taxotere Non Small Cell Lung Cancer DOCET_L_00730 NA NCT00378573
DOCETAXEL Taxotere Prostatic Neoplasms, Breast Neoplasms DOCET_L_02195 NA NCT00811447
DOCETAXEL Taxotere Prostatic Neoplasms, Breast Neoplasms DOCET_L_04203 MOTIF NCT00917748
DOCETAXEL Taxotere Lung Neoplasms DOCET_L_04827 TFINE NCT01038661
DOCETAXEL Taxotere Esophageal Neoplasms DOCET_R_03761 NA NCT00816543
DOCETAXEL TaxotereStomach Neoplasms DOCOX_C_00082 NA NCT00382720
DOCETAXELTaxotere Non Small Cell Lung Cancer DOCOX_L_00716 NA NCT00356122
DOCETAXEL Taxotere Nasopharyngeal Neoplasms EFC10339 NA NCT00565448
DOCETAXEL Taxotere Cancer, Head and Neck EFC6041 TAX316 NCT00688740
DOCETAXEL Taxotere Cancer, Head and Neck EFC6043 NA NCT00273546
DOCETAXEL Taxotere Cancer, Head and Neck EFC6044 NA NCT00290966
DOCETAXEL Taxotere Cancer, Head and Neck EFC6051 (XRP6976G/322) NA NCT00401323
DOCETAXEL Taxotere Breast Neoplasms RP56976_PR_315 BIG 02/98 NCT00174655
DOCETAXEL Taxotere Squamous Cell Carcinoma TAX_AT1_203 NANCT00432315
DOCETAXEL Taxotere Lung Neoplasms TAX_ES1_209NA NCT00258739
DOCETAXEL Taxotere Lung NeoplasmsTAX_ES1_302 NA NCT00174629
DOCETAXEL Taxotere Head and Neck neoplasms TAX_FR1_236 NA NCT00521521
DOCETAXEL TaxotereBreast Neoplasms TAX_GMA_301 NA NCT00312208
DOCETAXELTaxotere Breast Neoplasms TAX_IT1_302 NA NCT00174707
DOCETAXELTaxotere Breast Neoplasms XRP6976A_2504 RETAX NCT00620100
DOCETAXEL Taxotere Lung Neoplasms XRP6976B_2501 NA NCT00425191
DOCETAXEL Taxotere Lung Neoplasms XRP6976B_2503 NA NCT00263016
DOCETAXEL Taxotere Cancer, Non-Small-Cell Lung XRP6976B_2505 PULMONART NCT00174772
DOCETAXELTaxotere Lung Neoplasms XRP6976B_2506 ADVANCED EudraCT: 2004-001044-72
DOCETAXEL Taxotere Lung Neoplasms XRP6976B_2507 NA NCT00271323
DOCETAXEL Taxotere Lung Neoplasms XRP6976B_6020 CARBO-TAX NCT00826852
DOCETAXEL Taxotere Breast Neoplasms XRP6976D_2502 GETNA 2 NCT00617968
DOCETAXELTaxotere Breast Neoplasms XRP6976D_2504 NA NCT00461344
DOCETAXEL Taxotere Breast Neoplasms XRP6976D-311 NA NCT00002662
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976F_2501 NA NCT00357149
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976F_2502 NA NCT00916097
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976F_3501 NA NCT00539630
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976F_6002 NA NCT00436293
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976F_6007 TAX-NAZO NCT00772681
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976G_2501 NA NCT00268671
DOCETAXEL Taxotere Ovarian Neoplasms XRP6976I_2502 NA NCT00539669
DOCETAXEL Taxotere Ovarian Neoplasms XRP6976I_6012 TAX-OVER NCT00772863
DOCETAXEL Taxotere Prostatic Neoplasms XRP6976J_2501 NANCT00069888
DOCETAXEL Taxotere Prostatic Neoplasms XRP6976J_2503NA NCT00268710
DOCETAXEL Taxotere Prostatic Neoplasms XRP6976J_2504 NANCT00494338
DOCETAXEL Taxotere Prostatic Neoplasms XRP6976J_3501 NA NCT00283062
DOCETAXEL Taxotere Prostatic Neoplasms XRP6976J_3502 PROSTATAEudraCT: 2004-003885-14
DOCETAXEL Taxotere Prostatic NeoplasmsXRP6976J_3503 NA NCT00514917
DOCETAXEL TaxotereProstatic Neoplasms XRP6976J_4001 NA EudraCT: 2005-001873-91
DOCETAXEL Taxotere Stomach Neoplasms DOCET_L_00072 NEO-TAX NCT00343239
DOCETAXEL Taxotere Prostatic Neoplasms DOCET_L_01833 NA NCT00436839
DOCETAXEL Taxotere Neoplasms DOCET_L_04775 GRANOTAX NCT01107756
DOCETAXEL Taxotere Lung Neoplasms DOCET_L_05158C-CRISP NCT01266512
DOCETAXEL Taxotere Head and Neck neoplasms XRP6976F_2503 NA NCT00261703
DOCETAXEL Taxotere Breast Neoplasms TAX_GMA_302 NA EudraCT:2008-005127-29
DOCETAXEL Taxotere Squamous Cell Carcinoma DOCETL06445 NA NCT02061631
DOXERCALCIFEROL Hectorol Osteoporosis BCI-CH-102* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-106* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-108-LA* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-108-Memphis* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-110* NA
DOXERCALCIFEROL Hectorol Secondary Hyperparathyroidism BCI-CH-112* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-114-Memphis* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-115* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-119* NA
DOXERCALCIFEROL Hectorol Elevated Parathyroid Hormone Levels BCI-CH-120* NA
DOXERCALCIFEROL Hectorol Prostate Cancer BCI-CH-125* NA
DOXERCALCIFEROL Hectorol Seondary Hyperparathyroidism BCI-CH-126* NA
DOXERCALCIFEROL Hectorol Seondary Hyperparathyroidism BCI-CH-144*NA
DOXERCALCIFEROL Hectorol Seondary Hyperparathyroidism BCI-CH-147* NA
DOXERCALCIFEROL HectorolPsoriasis HECTPS02507 NA NCT00601107
DRONEDARONEMultaq Atrial Fibrillation DRI10939 NA NCT01213368
DRONEDARONEMultaq Atrial Fibrillation DRONE_L_05066 AFRODITE EudraCT: 2009-018215-53
DRONEDARONE Multaq Atrial Fibrillation EFC4968 DIONYSOS NCT00489736
DRONEDARONE Multaq Atrial Fibrillation EFC5555 ATHENA NCT00174785
DRONEDARONE Multaq Atrial Fibrillation EFC11405 PALLAS NCT01151137
DRONEDARONE Multaq Atrial Fibrillation DRONE_L_04742 ELECTRA NCT01026090
DRONEDARONE Multaq Atrial Fibrillation DRONE_L_04315 ODYSSEUS NCT01198873
DRONEDARONE Multaq Atrial Fibrillation DRONE_L_04316 HESTIA NCT01135017
DRONEDARONE Multaq Atrial FibrillationDRONE_L_03668 ARTEMIS Load EudraCT: 2009-016818-24
DRONEDARONEMultaq Atrial Fibrillation DRONE_L_04629 ARTEMIS Long Term EudraCT: 2010-019247-19
DROTAVERINE No-Spa Menstruation Disturbances L_8752 DOROTA NA
DROTAVERINE No-Spa Menstruation DisturbancesL_9134 NA EudraCT: 2004-003809-25
DUPILUMAB Not marketedNasal polyps ACT12340 NA EudraCT: 2013-001803-35
DUPILUMABNot marketed Asthma ACT11457 NA NCT01312961
DUPILUMAB Not marketed Asthma DRI12544 NA EudraCT: 2013-000856-16
DUPILUMAB Not marketed Asthma EFC13579 LIBERTY ASTHMA QUEST EudraCT: 2014-004940-36
DUPILUMAB Not marketed Asthma EFC13691 LIBERTY ASTHMA VENTURE EudraCT: 2015-001573-40


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK